ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,390Medicare Part D Prescriptions Filled, Including Refills

Rank: 122 out of 3734

$1.17M Total Retail Price of All Prescriptions

Rank: 53 out of 3734

1,147 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 1,147 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 1,147 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 12,859 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 654 514 1 1
HYDROCODONE-ACETAMINOPHEN 603 423 S3 2 12
LEVOTHYROXINE SODIUM 519 466 3 2
OMEPRAZOLE 480 373 4 4
LISINOPRIL 422 328 5 3
METOPROLOL TARTRATE 364 314 6 6
FUROSEMIDE 331 273 7 7
AMLODIPINE BESYLATE 311 249 8 5
PANTOPRAZOLE SODIUM 286 246 9 22
WARFARIN SODIUM 264 243 10 10
HYDROCHLOROTHIAZIDE 244 204 11 9
METFORMIN HCL 238 195 12 8
ATENOLOL 228 214 13 13
ATORVASTATIN CALCIUM 214 188 14 11
ZOLPIDEM TARTRATE 211 156 15 24
POTASSIUM CHLORIDE 207 145 16 19
OXYCODONE HCL 187 60 S2 17 58
BYSTOLIC 186 157 18 148
AZITHROMYCIN 180 137 19 38
DIOVAN 178 173 20 31
CLOPIDOGREL 160 144 21 23
BENICAR 154 141 22 107
CITALOPRAM HBR 153 97 23 16
SULFAMETHOXAZOLE-TRIMETHOPRIM 150 104 24 117
CELEBREX 149 123 25 69
DIGOXIN 145 134 26 43
ESCITALOPRAM OXALATE 132 90 27 68
ISOSORBIDE MONONITRATE ER 130 122 28 34
GABAPENTIN 129 88 29 17
CLONIDINE HCL 124 87 30 79
PLAVIX 119 110 31 39
DICLOFENAC SODIUM 112 77 32 127
PRAVASTATIN SODIUM 110 99 33 15
CYMBALTA 110 78 33 67
ZETIA 107 89 35 55
SYNTHROID 105 74 36 47
NEXIUM 101 80 37 36
TRADJENTA 99 87 38 476
CIPROFLOXACIN HCL 95 68 39 77
ALLOPURINOL 95 77 39 33
TAMSULOSIN HCL 93 77 41 29
GLIPIZIDE 90 71 42 57
LYRICA 90 60 42 124
LOSARTAN POTASSIUM 86 82 44 21
ADVAIR DISKUS 85 69 45 35
DIOVAN HCT 84 83 46 72
CARVEDILOL 82 76 47 30
ALENDRONATE SODIUM 81 68 48 26
RANITIDINE HCL 79 42 49 32
DONEPEZIL HCL 76 76 50 25
PRAMIPEXOLE DIHYDROCHLORIDE 75 75 51 192
FINASTERIDE 74 74 52 88
MIRTAZAPINE 74 69 52 45
TRAZODONE HCL 74 50 52 49
RISPERIDONE 73 57 55 62
VENLAFAXINE HCL ER 73 46 55 84
VENTOLIN HFA 73 51 55 70
PREDNISONE 73 52 55 42
KLOR-CON M20 72 72 59 48
MELOXICAM 72 48 59 52
DILTIAZEM 24HR CD 71 59 61 97
CEPHALEXIN 69 52 62 120
GLIMEPIRIDE 66 54 63 37
NAMENDA 64 64 64 44
AMITRIPTYLINE HCL 63 34 R 65 94
METOPROLOL SUCCINATE 62 55 66 14
CRESTOR 62 62 66 28
FLUOXETINE HCL 61 27 68 61
INSULIN SYRINGE 61 44 68 109
AMOXICILLIN 61 43 68 108
AMLODIPINE BESYLATE-BENAZEPRIL 60 47 71 56
IBUPROFEN 60 36 71 75
FLOVENT HFA 59 53 73 199
LANTUS SOLOSTAR 59 36 73 102
CLOTRIMAZOLE-BETAMETHASONE 58 32 75 135
WELCHOL 57 52 76 201
SPIRIVA 57 52 76 40
TRICOR 56 48 78 93
EXFORGE 56 54 78 183
PEN NEEDLE 56 47 78 152
SERTRALINE HCL 55 38 81 18
JENTADUETO 55 48 10 81 552
TRAMADOL HCL 54 19 83 20
OXYCODONE-ACETAMINOPHEN 54 52 S2 83 51
PAROXETINE HCL 54 46 83 59
SINGULAIR 51 29 86 95
BENICAR HCT 50 49 87 167
VIIBRYD 50 32 87 434
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.